Murdo Gordon serves as the Executive Vice President of Global Commercial Operations at Amgen Inc., a leading biotechnology company focused on developing innovative medicines for serious illnesses. With over two decades of experience in the pharmaceutical and biotechnology sectors, Gordon has been instrumental in driving Amgen's commercial success and global expansion. Prior to joining Amgen in 2015, he held various leadership positions at Pfizer, where he gained extensive experience in global marketing, sales, and business development. At Amgen, Gordon has been responsible for overseeing the company's worldwide commercial operations, including sales, marketing, and market access. Under his leadership, Amgen has successfully launched several blockbuster products, such as Prolia and Repatha, which have significantly contributed to the company's revenue growth and market share. Gordon's strategic vision and execution have been key factors in Amgen's ability to navigate the complex and competitive landscape of the biopharmaceutical industry. Throughout his career, Gordon has demonstrated a strong commitment to improving patient outcomes and advancing medical innovation. His leadership at Amgen has not only driven commercial success but also fostered a culture of collaboration and excellence within the organization. As EVP of Global Commercial Operations, Murdo Gordon continues to play a pivotal role in shaping Amgen's future, ensuring that the company remains at the forefront of the biotechnology industry while delivering life-changing therapies to patients worldwide.